Jazz Pharmaceuticals Inc. (JAZZ) reported fourth-quarter net income of $37.5 million or $0.79 per share, compared to $24.5 million or $0.56 per share in the prior year quarter.
On an adjusted basis, net income for the fourth quarter rose to $55.4 million or $1.17 per share from $27.2 million or $0.63 per share in the comparable quarter last year. On average, six analysts polled by Thomson Reuters expected earnings of $1.09 per share for the quarter. Analysts' estimates typically exclude one-time items.
Total revenues for the quarter were $83.54 million, compared with $53.37 million in the previous year quarter, while five analysts estimated revenues of $80.84 million for the quarter.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org